Financhill
Back

Kiora Pharmaceuticals, Inc. Vs. Crinetics Pharmaceuticals, Inc. Industry Stock Comparison

Sell
43

KPRX
Kiora Pharmaceuticals, Inc.

Last Price:
$2.24
Seasonality Move:
2.34%
Sell
34

CRNX
Crinetics Pharmaceuticals, Inc.

Last Price:
$55.06
Seasonality Move:
-11.9%
Sell
43
Kiora Pharmaceuticals, Inc. (KPRX) is a Sell

Is Kiora Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Kiora Pharmaceuticals, Inc. [KPRX] share price is $2.19. The Score for KPRX is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • KPRX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Crinetics Pharmaceuticals, Inc. (CRNX) is a Sell

Is Crinetics Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals, Inc. [CRNX] share price is $53.24. The Score for CRNX is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

KPRX Stock Price Chart

What is Kiora Pharmaceuticals, Inc.'s stock price today?

  • The Kiora Pharmaceuticals, Inc. share price today is $2.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KPRX is experiencing slight buying pressure.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals, Inc.'s stock price today?

  • The Crinetics Pharmaceuticals, Inc. share price today is $53.24
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRNX is experiencing slight selling pressure.

KPRX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 57.64 Buy
Chaikin Money Flow: 4822 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.98 - 2.16) Buy
Bollinger Bands (100): (2.09 - 2.73) Sell

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.28 Buy
Relative Strength Index (14 RSI): 65.68 Buy
Chaikin Money Flow: -209678 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (46.25 - 50.15) Buy
Bollinger Bands (100): (35.32 - 47.44) Buy

KPRX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.05 Buy
20-day SMA: 2.08 Buy
50-day SMA: 2.14 Buy
200-day SMA: 2.69 Sell
8-day EMA: 2.1 Buy
20-day EMA: 2.08 Buy
50-day EMA: 2.17 Buy
200-day EMA: 2.78 Sell

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.77 Buy
20-day SMA: 48.57 Buy
50-day SMA: 45.67 Buy
200-day SMA: 36.1 Buy
8-day EMA: 49.69 Buy
20-day EMA: 48.35 Buy
50-day EMA: 45.87 Buy
200-day EMA: 40.28 Buy

Kiora Pharmaceuticals, Inc. Earnings Growth & KPRX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.05 per share, and a decrease next year of $0.00 per share.

Crinetics Pharmaceuticals, Inc. Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and an increase next year of $1.51 per share.

Kiora Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):